Clinical Trials
- Melanoma
Melanoma Margins Trial-II - A Phase III, Multi-centre Randomised Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (02.18 MelMarT-II)
- Other Cancers
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630)
- Ages18 years and older
- GenderBoth
Molecular Markers of UV Exposure and Cancer Risk in Skin
- Men's Health, Women's Health
Preoperative Silicone Ointment and Wound Healing
- Ages18 years and older
- GenderBoth